Precision Medicine: Update and Priorities
A special issue of Diseases (ISSN 2079-9721). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 9074
Special Issue Editors
Interests: cardiovascular therapeutics; translational medicine; heart failure; cardio-metabolic disease
Special Issues, Collections and Topics in MDPI journals
Interests: cancers; diabetes; sudden cardiac death; rare diseases; hypercholesterolemia; cohort studies
Special Issue Information
Dear Colleagues,
Precision medicine has and continues to drive drug development and biomarker discovery for many diseases. Driven by a better understanding of the human genome, precision medicine has the potential to allow a better understanding of the causes and manifestations of diseases with the potential to identify biomarkers that could identify at risk patients. More recently, there has been much interest in the analysis of large population datasets to find personalized needs for more effective and safe treatment. These large population datasets will likely need artificial intelligence to help analyse these very large datasets. This Special Issue is within the section of Cardiology within Diseases and we wish to invite contributions in the field of cardio-metabolic diseases alongside all diseases, as we believe the prime moment has arrived, if new research is any indication.
Prof. Dr. Chim Lang
Prof. Dr. Rahman Jamal
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision medicine
- genomics
- non-communicable diseases
- therapeutics
- diagnostics
- biomarkers
- artificial intelligence
- drug safety
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
